The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Judge Tosses UnitedHealth Defamation Suit Against Guardian

A Delaware judge has dismissed UnitedHealth Group's defamation lawsuit against The Guardian, according to Becker's Hospital Review. Judge Scott granted all of the newspaper's motions to dismiss on the merits, ending the insurer's effort to challenge the outlet's reporting from last year.

The Guardian's coverage alleged that UnitedHealth secretly paid nursing homes to reduce hospital transfers for its Medicare Advantage members. UnitedHealth had sued, calling the reporting false and damaging. The court disagreed, letting the reporting stand and handing a win to the publication.

The outcome matters beyond the two parties. UnitedHealth remains under intense scrutiny over its Medicare Advantage business, and the dismissal signals that defamation claims are a steep hill for companies trying to counter unfavorable press. For insurers and health systems, the ruling reinforces that litigation is a risky tool against investigative journalism, and it keeps a spotlight on how Medicare Advantage plans manage care and costs at the point of hospitalization.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.